Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum

Journal of Hepatology

Volumn 54, Issue 4, 2011, Pages 666-673

  Lin, Ge ^a   Wang, Ji Yao ^b   Li, Na ^a   Li, Mi ^a   Gao, Hong ^b   Ji, Yuan ^b   Zhang, Fan ^c   Wang, Huali ^c   Zhou, Yan ^d   Ye, Yang ^e   Xu, Hong Xi ^d   Zheng, Jiang ^c  

^a Chinese University of Hong Kong   (Hong Kong)

^b FUDAN UNIVERSITY   (China)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^e SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Erroneous substitution; Hepatic sinusoidal obstruction syndrome; Pyrrole protein adducts; Pyrrolizidine alkaloids; Tusanqi

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CD34 ANTIGEN; CHINESE DRUG; COLLAGEN TYPE 1; COLLAGEN TYPE 3; COLLAGEN TYPE 4; DIURETIC AGENT; GAMMA GLUTAMYLTRANSFERASE; GLOBULIN; GYNURA SEGETUM EXTRACT; PYRROLIZIDINE ALKALOID; SENECIONINE; SENECIPHYLLINE; TUSANQI; UNCLASSIFIED DRUG;

ABDOMINAL DISTENSION; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANOREXIA; ARTICLE; ASCITES; BLOOD CELL COUNT; CASE REPORT; CONTROLLED STUDY; CRASSULACEAE; DRUG DETERMINATION; FEMALE; GYNURA SEGETUM; HEPATIC SINUSOIDAL OBSTRUCTION SYNDROME; HEPATOMEGALY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERBILIRUBINEMIA; LIVER BIOPSY; LIVER EDEMA; LIVER HEMORRHAGE; LIVER INJURY; LIVER STRUCTURE; LIVER TOXICITY; LIVER VEIN OBSTRUCTION; MALE; MASS SPECTROMETRY; MEDICINAL PLANT; MONITORING; NONHUMAN; PLEURA EFFUSION; PRIORITY JOURNAL; RAT; SEDUM AIZOON; THORAX RADIOGRAPHY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; WEIGHT GAIN;

ANIMALS; ASTERACEAE; DISEASE MODELS, ANIMAL; DRUG CONTAMINATION; DRUGS, CHINESE HERBAL; FEMALE; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; MALE; MIDDLE AGED; PLANTS, TOXIC; PYRROLIZIDINE ALKALOIDS; RATS; RATS, SPRAGUE-DAWLEY; SEDUM;

EID: 79952705842     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.07.031     Document Type: Article

References (45)

1. Helmy A. Updates in the pathogensis and therapy of hepatic sinusoidal obstruction syndrome. Aliment Pharm Ther 2006;23:11-25. (Pubitemid 43381162)
2. Fu PP, Xia QS, Lin G, Chou MW. Pyrrolizidine alkaloids-genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab Rev 2004;36:1-55. (Pubitemid 38387834)
3. Willmot FC, Robertson GW. Senecio disease or cirrhosis of the liver due to Senecio poisoning. Lancet 1920;2:848.
4. Dai N, Yu YC, Ren TH, Wu JG, Jiang Y, Shen LG, et al. Gynura root induces hepatic veno-occlusive disease: a case report and review of the literature. World J Gastroenterol 2007;13:1628-1631. (Pubitemid 46672677)
5. International Program on Chemical Safety. Health and safety guide no. 26: pyrrolizidine alkaloids health and safety guide. Geneva (Switzerland): World Health Organization; 1989.
6. Medicines and Healthcare products Regulatory Agency. Public consultation: proposals to prohibit the sale, supply or importation of unlicensed medicinal products for internal use which contain Senecio species and proposals to amend three existing orders; 2007 [monograph on the Internet].
7. U.S. Food and Drug Administration. FDA advises dietary supplement manufacturers to remove comfrey products from the market; 2001 [monograph on the Internet].
8. Zhang F, Wang CH, Xiong AZ, Wang W, Yang L, Branford-White CJ, et al. Quantitative analysis of total retronecine esters-type pyrrolizidine alkaloids in plant by high performance liquid chromatography. Anal Chim Acta 2007;605:94-101. (Pubitemid 350103781)
9. Cui YY, Lin G. Simultaneous analysis of clivorine and its four microsomal metabolites by high-performance liquid chromatography. J Chromatog A 2000;903:85-92.
10. Yang M, Li JY, Li XY, Cong LB, Zhu J, Xie H, et al. Simultaneous determination of senecionine, senciphylline, and senecionine N-Oxide in Gynura segetum by RP-HPLC. Anal Lett 2009;42:1820-1830.
11. Li SL, Lin G, Fu PP, Chan CL, Li M, Jiang ZH, et al. Identification of five hepatotoxic pyrrolizidine alkaloids in a commonly used traditional Chinese medicinal herb, Herba Senecionis scandentis (Qianliguang). Rapid Commun Mass Spectrom 2008;22:591-602. (Pubitemid 351300595)
12. Lin G, Zhou KY, Zhao XG, Wang ZT, But PPH. Determination of hepatotoxic pyrrolizidine alkaloids by on-line high performance liquid chromatography mass spectrometry with an electrospray interface. Rapid Commun Mass Spectrom 1998;12:1445-1456. (Pubitemid 28485969)
13. Qi X, Wu B, Cheng Y, Qu H. Simultaneous characterization of pyrrolizidine alkaloids and N-oxides in Gynura segetum by liquid chromatography/ion trap mass spectrometry. Rapid Commun Mass Spectrom 2009;23:291-302.
14. Qi X, Wang S, Wu B, Qu H. Sensitive determination of hepatotoxic pyrrolizidine alkaloids in Gynura segetum by micellar electrokinetic chromatography (MEKC). Chromatographia 2009;70:281-285.
15. Kempf M, Beuerle T, Bühringer M, Denner M, Trost D, von der Ohe K, et al. Pyrrolizidine alkaloids in honey: risk analysis by gas chromatography-mass spectrometry. Mol Nutr Food Res 2008;52:1193-1200.
16. Xia QS, Chou MW, Lin G, Fu PP. Metabolic formation of DHP-derived DNA adducts from a representative otonecine type pyrrolizidine alkaloid clivorine and the extract of Ligularia hodgsonnii Hook. Chem Res Toxicol 2004;17:702-708.
17. Lin G, Li SL, Li M, Li N, Chan SSK, Chan WY, et al. Qianliguang (Senecio scadens) safety dilemma: dose is the key? Planta Med 2009;75:1-5.
18. Lin G, Nnane IP, Cheng TY. The effects of pretreatment with glycyrrhizin and glycyrrhetinic acid on the retrorsine-induced hepatotoxicity in rats. Toxicon 1999;37:1259-1270. (Pubitemid 29236212)
19. Lin G, Cui YY, Liu XQ. Gender differences in microsomal metabolic activation of hepatotoxic clivorine in rat. Chem Res Toxicol 2003;16:768-774. (Pubitemid 36736608)
20. Lin G, Cui YY, Hawes EM. Characterization of rat liver microsomal metabolites of clivorine, a hepatotoxic otonecine-type pyrrolizidine alkaloid. Drug Metab Disp 2000;28:1475-1483.
21. Lin G, Tang J, Liu XQ, Jiang Y, Zheng J. Deacetylclivorine: a gender-selective metabolite of clivorine formed in female Sprague-Dawley rat liver microsomes. Drug Metab Dispos 2007;35:607-613. (Pubitemid 46513264)
22. Yan CC, Huxtable RJ. Relationship between glutathione concentration and metabolism of pyrrolizidine alkaloid, monocrotaline, in the isolated, perfused liver. Toxicol Appl Pharmacol 1995;130:132-139.
23. Danan G, Benichou C. Causality assessment of adverse reactions to drugs-I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993;46:1323-1330. (Pubitemid 23333873)
24. Health Department and National Chinese Medicine Management Office. Zhonghua Bencao. vol. 3. Shanghai: Shanghai Science and Technology Publishing House; 1999; p. 765-6.
25. Lin G, Cui YY, Hawes EM. Microsomal formation of a pyrrolic alcohol glutathione conjugate of clivorine, firm evidence for the formation of pyrrolic metabolite of an otonecine-type pyrrolizidine alkaloid. Drug Metab Disp 1998;26:181-184. (Pubitemid 28104087)
26. Lacorte S, Fernandez-Alba AR. Time of flight mass spectrometry applied to the liquid chromatographic analysis of pesticides in water and food. Mass Spectrom Rev 2006;25:866-880. (Pubitemid 44727513)
27. Vanherwegham JL, Depierreux M, Tielemans C, Abramowicz D, Dratwa M, Jadoul M, et al. Rapidly progressive interstitial fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 1993;341:387-391. (Pubitemid 23048140)
28. Wu GL, Yu GY, Chen J. Clinical analysis of hepatic veno-occlusive disease induced by Sedum aizoon. China J Chin Mater Med 2008;33:2402-2404.
29. Ma XG. Sonogaphic characteristics of hepatic veno-occlusive disease. Zhejiang Clin Med J 2008;10:593-594.
30. Liu JH, Pu XK, Wu YF. Clinical and pathological diagnosis of hepatic venoocclusive disease. J Clin Hepatol 2008;11:107-109.
31. Zhang MP, Shi HR, Zhang YZ. Treatment of hepatic veno-occlusive disease induced by overdose of Gynura segetum. Zhejiang J Trauma 2009;14:90.
32. Huang JG. Treatment of 8 cases of hepatic veno-occlusive disease induced by Tusanqi. Mod J Integr Trad Chin West Med 2009;18:412.
33. Huang HJ, Liu Y, Lin JS, Li DM. The diagnosis and treatment of hepatic venoocclusive disease induced by Gynura root. Chin J Clin Gastroenterol 2008;20:26-29.
34. Li SR, Yang L, Xiong LN, Hu SJ, Ye J. A case report of wrong diagnosis of hepatic veno-occlusive disease and review of the literature. Chin J Integr Trad West Med Liver Dis 2007;17:251-252.
35. Li YX, Du N, Wang F, Lv XM. Two cases of hepatic veno-occlusive disease induced by Tusanqi. Chin J Clin Hepatol 2006;22:319-320.
36. Pang L, Fan YH, Wang XT, Wang TL. Two cases of veno-occlusive disease and review. Chin J Gastroenterol Hepatol 2008;17:513-516.
37. Chen WX, Yang M, Yu ZH, Li YM. Two cases of hepatic veno-occlusive disease induced by Tusanqi. Chin J Hepatol 2005;13:394-395.
38. Yan H, Bai L, Peng M. A case report of acute liver damage induced by Jusanqi. Chin Hepatol 2005;10:344.
39. Li JP, Hu MH, Jin HH, Dai T, Zhu LF. Treatment of hepatic veno-occlusive disease by orthotopic liver transplantation. Chin J Hepatobil Surg 2001;7:cover 2.
40. Chen MY, Cai JT, Du Q. Hepatic veno-occlusive disease associated with the use of Gynura segetum. Europ J Intern Med 2007;18:609. (Pubitemid 350186239)
41. Yuan SQ, Gu GM, Wei TT. Alkaloids of Gynura segetum (Lour.) Merr. Acta Pharm Sin 1990;25:191-197.
42. Jiangsu New Medicinal College. Dictionary of Chinese Herbal Medicine. Shanghai: People's Publishing House; 1977.
43. Mattocks AR, White INH. Estimation of metabolites of pyrrolizidine alkaloids in animal tissues. Anal Biochem 1970;38:529-535.
44. Steenkamp V, Stewart MJ, Zuckerman M. Clinical and analytical aspects of pyrrolizidine poisoning caused by South African traditional medicines. Ther Drug Monit 2000;22:302-306. (Pubitemid 30346446)
45. Rasenack R, Müller C, Kleinschmidt M, Rasenack J, Wiedenfeld H. Venoocclusive disease in a fetus caused by pyrrolizidine alkaloids of food origin. Fetal Diagn Ther 2003;18:223-225. (Pubitemid 36831168)